Navigation Links
Asymmetrex Announces Plans to Provide Free Tissue Stem Cell Counting
Date:6/19/2020

The director of stem cell biotechnology company Asymmetrex, Dr. James L. Sherley, M.D., Ph.D., is betting that if the stem cell medicine and pharmaceutical industries have easier access to stem cell counting, they will soon make it a routine part of their practice. So, starting July 5 of this year, Independence Day weekend in the U.S., Asymmetrex is offering free tissue stem cell counting at its website.

Obtaining a free stem cell count will only require entry of simple total cell count data at the company’s website. Counting total cells is a widely used, common practice throughout academic cell science, industrial cell manufacturing, drug development, and clinical medicine. However, counting tissue stem cells is only possible with Asymmetrex’s AlphaSTEM Test™ software technology. Simple cell culture procedures will be provided at the free stem cell count site. By following the simple cell culture and total cell counting procedures, any basic cell culture lab can generate the data needed for Asymmetrex to deliver a tissue stem cell-specific count to them in short order.

Asymmetrex’s tissue stem cell counting technology is a recent development for the industry. So, presently, its value is not widely known. There are many examples where the need for tissue stem cell counting has been ignored for years, because previously there was no way to do it. Counting would improve the design and interpretation of tissue stem cell research. Counting tissue stem cells would allow better optimization of cell and tissue manufacturing processes. Counting would provide better quality control for produced and transported tissue stem cell products. Counting would provide crucial dosages for stem cell treatments and stem cell clinical trials. Counting cord blood stem cells would make leukemia treatments for children more reliable. Counting tissue stem cells would provide inexpensive, early identification of stem cell-toxic drug candidates that would fail later in expensive clinical trials.

The planned free stem cell counting site is a part of Asymmetrex’s campaign to increase academic and industry awareness of the need for tissue stem cell counting and its value. In an earlier podcast series on “Counting Stem Cells” featured on the international stem cell industry networking platform RegMedNet, Director Sherley discusses the benefits of Asymmetrex’s technology for stem cell research, stem cell medicine, tissue stem cell biomanufacturing, pharmaceutical development, and environmental health science. Sherley now expects that, “The new free tissue stem cell counting site will give members of our industry the freedom to rediscover, for themselves, the value of counting.”

About Asymmetrex

Asymmetrex, LLC is a Massachusetts life sciences company with a focus on developing technologies to advance stem cell medicine. Asymmetrex’s founder and director, James L. Sherley, M.D., Ph.D. is an internationally recognized expert on the unique properties of adult tissue stem cells. The company’s U.S. and U.K. patent portfolio contains biotechnologies that solve the two main technical problems – production and quantification – that have stood in the way of successful commercialization of human adult tissue stem cells for regenerative medicine and drug development. In addition, the portfolio includes novel technologies for isolating cancer stem cells and producing induced pluripotent stem cells for disease research purposes. Asymmetrex markets the first technology for determination of the dosage and quality of tissue stem cell preparations (the “AlphaSTEM Test™”) for use in stem cell transplantation therapies, cell biomanufacturing, and pre-clinical drug evaluations. Asymmetrex is a member company of the Advanced Regenerative Manufacturing Institute BioFabUSA and the Massachusetts Biotechnology Council.

Read the full story at https://www.prweb.com/releases/asymmetrex_announces_plans_to_provide_free_tissue_stem_cell_counting/prweb17189881.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Asymmetrex Proposes “Stemgene Therapy” to Emphasize the Importance of Tissue Stem Cells for Successful Gene Therapy
2. Asymmetrex Suggests a Stemgene Relief from Recent Cancer Woes About CRISPR-Cas9 Gene-Editing Therapies
3. Asymmetrex Publishes Chapter Explaining the Critical Need for Stem Cell Dosing for Success in Stem Cell Medicine
4. Asymmetrex Presents Proposal for ASTM Interlaboratory Evaluation of AlphaSTEM Test™ Technology Towards Establishing A Standard for Counting Therapeutic Stem Cells
5. Asymmetrex Approved to Conduct an ASTM Interlaboratory Evaluation of Its AlphaSTEM Test™ Technology as a Standard for Counting Therapeutic Adult Tissue Stem Cells
6. New Podcast Sponsored by Asymmetrex Increases Awareness to the Need for Stem Cell Dose in Stem Cell Treatments
7. Asymmetrex Partners in Manufacturing USA Institute
8. Asymmetrex Announces New Algorithms for Rapid Low Cost Counting of Therapeutic Tissue Stem Cells
9. Merck Animal Health announces Vetsulin
10. AAPS announces 2013 National Biotechnology Conference award winners
11. PLOS announces Accelerating Science Award Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology: